5 studies were found.

1.		Completed	Safety and efficacy study of the vasopressin receptor antagonist conivaptan in patients with acute decompensated heart failure Condition: Congestive Heart Failure
2.		Completed	A study to evaluate the effects of YM872 on brain function and disability when administered in combination with alteplase (tissue plasminogen activator) Condition: Acute ischemic stroke
3.		Completed	A study to evaluate the effects of YM872 on stroke lesion volume in acute stroke patients Condition: Cerebrovascular Accident
4.		Terminated	YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy Conditions: Hormone-Refractory Prostate Cancer; Prostatic Neoplasms
5.		Terminated	YM598 in patients with rising PSA after initial therapy for localized prostate cancer Condition: Prostate Cancer